glp-1 drugs with least side effects GLP-1s for Weight Loss: What You Need to Know Part 2 of a 3-Part

In a Phase II readout released in August 2022, the pharma touted a 15.6% drop in body weight in patients taking CagriSema, versus 5.1% in comparators on semaglutide alone and 8.1% in patients treated with only cagrilintide

And, critically for this discussion, it slows gastric emptying, the rate at which food moves from your stomach into your small intestine

25.5% HbA1c Liraglutide , 2-3 kg

It can also be easier for insurance companies to cover bariatric surgery due to it being a one-time, permanent solution for weight loss, rather than an ongoing medication

These will provide data on long-term safety, cardiovascular outcomes, renal effects, and efficacy in populations with type 2 diabetes, sleep apnea, and chronic back pain

#AddictionResearch #Neuroscience #GLP1 #Endocrinology #SubstanceUseDisorders #CitationAnalysis #ScientificLiterature #ResearchWorkflow #Scite To view or add a comment, sign in With $285M from its IPO, LB Pharmaceuticals Inc will fund new trials of its investigational drug LB-102 for schizophrenia and bipolar depression